Stockreport

Arthrosi Appoints John Leaman, M.D., to Its Board of Directors [Yahoo! Finance]

Cartesian Therapeutics, Inc.  (RNAC) 
PDF potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with gout, today announced the appointment of John Leaman [Read more]